Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma

NCT02011594 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped There was no participants enrolled in this clinical trial.

Conditions

Stage IV Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Nimotuzumab
DRUG: Placebo

Sponsor

Zhejiang University